diabetestalk.net

T Slim X2 Insulin Pump

Tandem T:slim X2 Approved In Canada

Tandem T:slim X2 Approved In Canada

On Friday, October 12, 2018, Health Canada announced approval of the t:slim X2 insulin pump for users in Canada. This comes only days after a Health Canada approval of the Medtronic 670G insulin pump. Sales are expected to begin soon Fall 2018. Read on to learn a bit more about the t:slim X2 originally published by our friends up in Canada, Connected In Motion , on their blog! Im just getting to know Tandem. Can you tell me a bit more about the company? You might have heard the rumours that there is (/will soon-we-think be) a new kid on the block in the Canadian Insulin Pump world, Tandem Diabetes . Connected in Motion has been working with Tandem in the US for several years and are excited to share some of what weve learned from our experiences here with our community. Tandem focuses on innovative and a user-centric approach when it comes to the design, development and sale of their insulin pumps. They sell the t:slim X2 Insulin Pump. You might have heard about it! Its the touch-screen 300 unit pump that is capable ofremote feature updates using a personal computer. ( You might remember the blog we wrote about it! ) Tandem also makes a larger, 480-unit pump for users with greater insulin needs, including our T2 friends! Tandem, a San Diego-based company, really puts design and user-experience at the centre of their innovation. When they developed their first pump, they conducted thousands of interviews with people living with diabetes and their healthcare providers, and have continued using this design approach in the development of all of their products. Another cool thing to know about Tandem is that diabetes isallthey do. Insulin pumps are not a division of a larger company. Their insulin pump has been used in artificial pancreas studies around the world. Reservoir Continue reading >>

Tandem Diabetes Care Receives Ce Mark For T:slim X2 Insulin Pump

Tandem Diabetes Care Receives Ce Mark For T:slim X2 Insulin Pump

Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump Tandem Diabetes Care, Inc. ( TNDM ), a medical device company and manufacturer of the only touchscreen insulin pumps, today announced receipt of CE mark approval for the t:slim X2 Insulin Pump with Dexcom G5 Mobile continuous glucose monitoring (CGM) integration1. The Company plans to begin commercial sales of the pump in select international markets beginning in the second half of 2018. The Company has been commercializing its touchscreen insulin pumps in the United States since 2012, and received U.S. Food and Drug Administration (FDA) approval of the t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM integration in August 2017. The simple-to-use t:slim X2 Insulin Pump includes advanced features like a large color touchscreen, rechargeable battery, USB connectivity and watertight construction (IPX7)2. It is the only pump that integrates with Dexcom G5 Mobile CGM, and the first CGM-enabled pump approved to let users make treatment decisions without pricking their finger.3 The t:slim X2 Pump is up to 38% smaller than other insulin pumps and holds up to 300 units of insulin.4 As our first product to receive CE mark, this milestone is key to the fulfillment of our vision to bring the features and benefits of our unique insulin pump technology to people outside of the United States, said Kim Blickenstaff, President and CEO of Tandem Diabetes Care. Our plans to launch the t:slim X2 Pump internationally in the second half of this year is of particular strategic importance during this time where insulin pump options are becoming increasingly limited." Tandem Diabetes Care, Inc. ( www.tandemdiabetes.com ) is a medical device company dedicated to improving the lives of people with diabetes through relentless innova Continue reading >>

T:slim X2 Insulin Pump

T:slim X2 Insulin Pump

Tandem allows t:slim X2 Insulin Pump users to remotely update features on their insulin pump using a personal computer, without having to wait for a whole new pump. The t:slim X2 Insulin Pump is the pump that gets updated, not outdated.^1 Touchscreen technology makes the t:slim X2 Insulin Pump simple to learn and simple to use, so whether new to pump therapy or well acquainted, the t:slim X2Insulin Pump was designed to be user friendly. You can now experience the simple touchscreen interface of the t:slim X2 Insulin Pump on theFREE t:simulatorTMApp. Download this educational tool on your compatible smart device today through The App Store or Google Play . The beauty of the t:slim X2Insulin Pump is that it has a slim and sleek design yet it can hold a surprisingly large amount of insulin up to 300 units. All thanks to our Micro-deliverytechnology and an innovative, flat insulin cartridge design. The t:slim X2 Insulin Pumps rechargeable battery can be charged from a wall outlet, the car, a power pack, or a computer without interrupting insulin delivery. A charge lasts up to 7 days, so there is no need to worry about purchasing extra batteries! The t:slim X2 Insulin Pump is ultra-strong the aluminum case is very durable and light. The touchscreen is made of high grade, shatter-resistant glass. Plus, the t:slim X2 Insulin Pump is watertight,3so there is no need to worry about it accidentally getting wet. Personalise the t:slim X2 Insulin Pump to deliver a steady amount of insulin to meet changing needs throughout the day and night. This is called basal delivery. The t:slim X2 Insulin Pump delivers mealtime insulin, also called a bolus, using a simple, colour touchscreen and an integrated bolus calculator with carb adding capabilities. View insulin delivery history right on Continue reading >>

T:slim X2 Insulin Pump

T:slim X2 Insulin Pump

See more information about t:slim X2 Insulin Pump, find and apply to jobs that match your skills, and connect with people to advance your career. The smallest insulin pump is also the only pump capable of remote feature updates using a personal computer.(1, 2) And now the t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM integration is the first CGM-enabled pump that is approved to let you make treatment decisions without pricking your finger.(3)1. 38% smaller than MiniMed 630G and 670G and 25% smaller than MiniMed 530G, Animas Vibe and Omnipod System. Data on file, Tandem Diabetes Care.2. Software updates and new features are subject to future FDA approvals. Charges may apply.3. CGM-based treatment requires fingersticks for calibration; may result in hypoglycemia if calibration not performed, when taking acetaminophen, or if symptoms/expectations do not match CGM readings.Indications for Use: RX ONLY. The t:slim X2 Insulin Delivery System is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin for individuals 6 years of age or greater. The t:slim X2 Insulin Pump can be used solely for continuous insulin delivery and/or as part of the t:slim X2 System to receive and display continuous glucose measurements from the Dexcom G5 Mobile Sensor and Transmitter. The t:slim X2 System also includes continuous glucose monitoring (CGM) indicated for the management of diabetes. The Dexcom G5 Mobile CGM is designed to replace fingerstick blood glucose testing for diabetes treatment decisions. The t:slim X2 System combined with the Dexcom G5 Mobile CGM aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments, which may mini Continue reading >>

The T:slim X2 Pump Is Up To 38% Smaller Than Other Pumps,1 But Is Packed With Big Features.

The T:slim X2 Pump Is Up To 38% Smaller Than Other Pumps,1 But Is Packed With Big Features.

*A prescription and additional training may be required to access certain future software updates. Offer only available to customers in the United States. 38% smaller than MiniMed 630G and 670G and at least 28% smaller than MiniMed 530G, Animas Vibe and Omnipod System. Data on file, Tandem Diabetes Care. Additional feature updates are not currently available for the t:slim X2 Pump with Dexcom G5 CGM integration and are subject to future FDA approvals. Charges may apply. Dexcom G5 Mobile CGM sold separately. CGM coverage may vary based on insurance. Please consult your CGM supplier for coverage information. Tested to a depth of 3 feet for 30 minutes (IPX7). CGM-based treatment requires fingersticks for calibration; may result in hypoglycemia if calibration not performed, when taking acetaminophen, or if symptoms/expectations do not match CGM readings. The Dexcom G5 Mobile CGM transmitter can only be paired with one medical device (either a Dexcom receiver or t:slim X2 Pump) and one consumer device (phone or tablet) at the same time. dQ&A USA Diabetes Connections Surveys, 2009-2017. Dexcom G5 Mobile CGM User Guide, 2017. Following your shared data requires the Dexcom Follow app. dQ&A USA Diabetes Connections Surveys, 2013-2017. Indications for Use: RX ONLY. The t:slim X2 Insulin Delivery System is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin for individuals 6 years of age or greater. The t:slim X2 Insulin Pump can be used solely for continuous insulin delivery and/or as part of the t:slim X2 System to receive and display continuous glucose measurements from the Dexcom G5 Mobile Sensor and Transmitter. The t:slim X2 System also includes continuous glucose monitoring (CGM) Continue reading >>

First Week With My Tandem T:slim X2 Insulin Pump

First Week With My Tandem T:slim X2 Insulin Pump

I have been contemplating my next insulin pump decision for months, if not over a year now. With different insulin pumps on the market, and with the promise of more to come in the next couple of years, I was hesitant to make a decision by the end of November as to what to do. However, with the uncertainty if my husband’s insurance was going to change again, we decided to go ahead and make the purchase. Choosing the X2 I chose to go with Tandem again after closely following the arrival of their t:slim X2 insulin pump. With the possibility of not only connecting to Dexcom’s G5 transmitter, but being able to do so without sending in my pump for a replacement and without additional cost (as per their earning’s call), I really couldn’t see myself going with another insulin pump. It’s true – I haven’t had the best 4 years initially with Tandem, but after receiving my last replacement (due to a broken screen) and seeing and experiencing the new software (which included my much needed updated reverse correction that would allow me to choose whether or not the pump reduced my bolus if I was below my target but above 70mg/dL), I was swayed more toward Tandem. Then, of course, the touch-screen had a factor in it too, not because of it being “flashy” or “with the times” but because after using my friend’s Animas Vibe during my pregnancy, I realized how much more time it took to scroll rather than tap the information I needed into the pump. Oh, and the rechargeable factor is always a win in my book as I hate buying batteries. I also loved that I could upload the t:slim to Diasend, Tidepool, or t:connect, and do so using a standard micro-USB cable instead of some fancy wired dongle that I could never keep up with. After a week wait of submissions and requests, Continue reading >>

Tandem Diabetes Care Announces Fda Approval Of T:slim X2 Insulin Pump With Basal-iq Technology

Tandem Diabetes Care Announces Fda Approval Of T:slim X2 Insulin Pump With Basal-iq Technology

Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology New Predictive Low Glucose Suspend Feature to Launch with Dexcom G6 CGM System Integration June 21, 2018 04:05 PM Eastern Daylight Time SAN DIEGO--( BUSINESS WIRE )--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced U.S. Food and Drug Administration (FDA) approval of the t:slim X2 Insulin Pump with Basal-IQ technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia). This is the first automated insulin delivery system approved for use by children as young as 6 years old, and the first insulin pump designated as compatible with integrated continuous glucose monitoring (iCGM) devices. The Company plans to launch its new product with Dexcom G6 continuous glucose monitoring (CGM) integration, which requires no fingersticks for calibration or diabetes treatment decisions and was the first CGM device to receive the iCGM designation from the FDA earlier this year.1,2,3 Tandem expects the t:slim X2 Pump with Basal-IQ technology to be available in August 2018, and all in-warranty t:slim X2 users in the United States will have the option to add the new feature free of charge via remote software update.4 Tandems Basal-IQ algorithm is designed to look 30 minutes into the future to predict where glucose levels are heading. The device suspends insulin delivery when low glucose is predicted, then automatically resumes insulin delivery once glucose levels begin to rise. Use of the t:slim X2 Pump with Basal-IQ technology in the pivotal clinical study demonstrated a 31 percent relative re Continue reading >>

The Benefits Of Tandems T:slim X2 Insulin Pump

The Benefits Of Tandems T:slim X2 Insulin Pump

When it comes to type 1 diabetes, my husband and I have always been resistant to change. A year after Bisi was diagnosed, when it came time for her to start on an insulin pump, we dawdled, because we felt used to and comfortable with the routine of multiple daily injections. But once Bisi started using the Omnipod, we quickly realized how much easier it was, both for her and for us. Last winter, Bisi started saying she wanted to try a different pump. She didnt like the Omnipod interface, which hadnt changed in the five years shed been using the system. She said that when she ran around, she could feel the pod (and the cannula in her skin) bouncing around. And a few times during sports, the pod sheared off her body. Again, Mark and I were resistant to a change. The Omnipod is so convenient: we could easily give Bisi boluses or change her basal while she slept. She didnt have to worry about taking it off for sports, swimming, or showers. It was so easy to wear, without any of the negotiations of a tubed pump in terms of how to attach it to your clothes. For several months, Bisi pressed us to initiate the change, but again we dawdled. But, about a month ago, she finally switchedfrom the Omnipod to the t:slim X2 (and, less of a big deal, from the Dexcom G5 to the G6). Once again, Bisi was right. The change has been great for several different reasons. Bisi started on the Omnipod when she was seven. While she understood how to bolus, she was young enough that Mark and I were in full control of the pump and its settings. Because the Omnipod controller wasnt attached to Bisis body, it was very easy for us to do many of the boluses and temporary changes in basal rates ourselves. This was super convenient, but I think we didnt hand it over to Bisi as quickly or as often as we s Continue reading >>

T:slim X2tm Insulin Pump Southeast Diabetes, Inc

T:slim X2tm Insulin Pump Southeast Diabetes, Inc

Touchscreen technology makes the t:slim X2 Pump simple to learn and simple to use, so whether youre new to pump therapy or experienced, the t:slim X2 Pump was designed for you. Upon FDA approval of Dexcom G5 Mobile CGM compatibility, thousands of existing t:slim X2 Pump users were able to add CGM integration to their pump from home using their personal computer. The t:slim X2 Pump also incorporates familiar technology such as an integrated micro-USB port for convenient charging and fast data transfer speeds. The t:slim X2 Pump is ultra strong. Its aluminum body is very durable and light, and the touchscreen is made of high-grade, shatter-resistant glass. Plus, the t:slim X2 Pump is watertight,5 so you dont have to worry if it accidentally gets wet. The t:slim X2 Insulin Pump with Dexcom G5 Mobile continuous glucose monitoring (CGM) integration is the only CGM-enabled pump approved to let you make treatment decisions without pricking your finger.6-7 1.Programmable high and low alert settings notify you when your glucose is above or below your personal target range. 2.Color-coded trend lines make it easy to spot trends at a glance. 3.Current glucose value tells you where you are now. 4.Trend arrow helps you catch high and low glucose levels before they happen. When CGM is turned off, the t:slim X2 Pump removes the CGM chart and puts the Bolus and Options buttons in the center of the screen for easy access. Dexcom is the #1 preferred continuous glucose monitoring (CGM) brand.8. Can transmit real-time glucose data to compatible mobile devices and be shared with loved ones and caregivers 10. With just a few taps, you can view your insulin delivery and glucose history right on the t:slim X2 Pumps bright color screen. You can also quickly upload your insulin delivery and CGM Continue reading >>

Fda Approves Tandem’s T:slim X2 Pump With Integrated Dexcom G5 Cgm

Fda Approves Tandem’s T:slim X2 Pump With Integrated Dexcom G5 Cgm

By Maeve Serino and Adam Brown Free software upgrade for t:slim X2 users, first G5-integrated pump on the market, CGM can be used for insulin dosing and remote monitoring Tandem just recently announced FDA approval and launch of its t:slim X2 insulin pump with integrated Dexcom G5 CGM. The update allows data from the G5 CGM transmitter to be sent directly to the t:slim X2 insulin pump screen, both a convenience win and paving the way for future critical updates that add automated insulin delivery. The t:slim X2 with G5 is approved for people 6 years and older, and users can still see their CGM data at the same time on Dexcom’s own iOS and Android smartphone apps. Tandem is the first company to launch a Dexcom G5-integrated pump – Animas’ One Touch Vibe Plus was approved last December, but still hasn’t launched. Current t:slim X2 users can add G5 integration to their pump for free using the Tandem Device Updater (check out diaTribe columnist Kerri Sparling’s post on how easy it is to do!). These customers will receive an email with instructions on how to update their pump’s software at home. Updating insulin pump software at home for free allows people with diabetes to avoid the hassle and cost of getting a new pump – a major win. With its software update capabilities, Tandem’s t:slim X2 can now keep up with innovations that happen within a pump’s four-year warranty cycle. Similar to the standalone G5, Dexcom data displayed on the t:slim X2 can be used for insulin dosing decisions. The G5 still requires two fingersticks per day for calibration, and these can be entered on the pump screen or in Dexcom’s smartphone app. Since the G5 on-body transmitter can communicate with both the t:slim X2 and G5 app, using one device will automatically update the oth Continue reading >>

T:slim X2 Insulin Pump With Dexcom G5 Cgm Connectivity Cleared In Eu

T:slim X2 Insulin Pump With Dexcom G5 Cgm Connectivity Cleared In Eu

t:slim X2 Insulin Pump with Dexcom G5 CGM Connectivity Cleared in EU Tandem Diabetes Care finally won European regulatory clearance to introduce its t:slim X2 insulin pump. The device can be reprogrammed and upgraded in order to be able to interface with other devices and to take advantage of newly introduced algorithms and features. As a major first capability provided by this is the compatibility with the Dexcom G5 continuous glucose monitor and an algorithm that stops insulin delivery when it calculates a high chance for a case of hypoglycemia. The device is controlled via its touchscreen and Bluetooth wireless connectivity allows for transfer of data between the pump and other devices, as well as leaving potential open for sending and receiving control commands from trusted sources. Because the interface resembles common smartphones, you can even download a simulator app (t:simulator) to see how youd use and control the pump.A rechargeable battery powers the device and it holds 300 units of insulin when full. And because its waterproof, you can even take it swimming. Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004. 25feballday27alldayField Service Medical 2019San Diego, CA, USA We launched Field Service in 2002 and have been dedicated to supporting the growth of the service industry ever since. We launched Field Service in 2002 and have been dedicated to supporting the growth of the service industry ever since. What started off as 100 people in a room discussing the future of service has become 500 senior-level service executives being inspired while learning and developing their Continue reading >>

T:slim X2 Insulin Pump With Basal-iq Technology - P180008

T:slim X2 Insulin Pump With Basal-iq Technology - P180008

t:slim X2 Insulin Pump with Basal-IQ Technology - P180008 This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA's approval. Product Name: t:slim X2 Insulin Pump with Basal-IQ Technology PMA Applicant: Tandem Diabetes Care, Inc. Address: 11045 Roselle Street Suite 200, San Diego, CA 92121 Approval Letter: What is it? The t:slim X2 Insulin Pump with Basal-IQ Technology (the System) consists of a continuous glucose monitor (CGM) and an insulin pump with Basal-IQ technology. The System is intended to monitor glucose (sugar) levels and to deliver insulin for the management of diabetes. The Basal IQ technology feature of the insulin pump predicts whether glucose levels will fall below a predefined threshold to suspend insulin delivery. Diabetes is a disease in which your blood sugar or blood glucose levels can go too low or too high. How does it work? The t:slim X2 Insulin Pump with Basal-IQ Technology works by measuring glucose levels and automatically adjusts insulin delivery by either administering or withholding insulin. The t:slim X2 Insulin Pump with Basal-IQ Technology is designed to communicate with a CGM to continuously display glucose readings, trend information, alerts, alarms, in addition to infusion pump data. The CGM measures sugar (glucose) levels and the insulin pump can be programmed to automatically suspend delivery of insulin when the sensor glucose level falls below a predefined glucose level. Every 5 minutes, the Basal-IQ technology feature of the insulin pump assesses the user's glucose information provided by the CGM and predicts Continue reading >>

Tandem Diabetes Care Announces Commercial Launch Of T:slim X2 Insulin Pump With Basal-iq Technology In The United States

Tandem Diabetes Care Announces Commercial Launch Of T:slim X2 Insulin Pump With Basal-iq Technology In The United States

Tandem Diabetes Care Announces Commercial Launch of t:slim X2 Insulin Pump with Basal-IQ Technology in the United States Tandem Diabetes Care, Inc. TNDM, +4.50% a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2 Insulin Pump with Basal-IQ Technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia). It is integrated with the Dexcom G6 CGM System, which requires no fingersticks for calibration or diabetes treatment decisions. [1,2] The Company has begun sending emails with update instructions to all in-warranty t:slim X2 users in the United States, who have the option to add the new feature free of charge via remote software update. [3] t:slim X2 Pumps pre-loaded with Basal-IQ Technology are expected to begin shipping to new customers by the end of August. Tandems Basal-IQ algorithm is designed to look 30 minutes into the future to predict where glucose levels are heading. The device suspends insulin delivery when low glucose is predicted, then automatically resumes insulin delivery once glucose levels begin to rise. In the pivotal clinical study, use of the t:slim X2 Pump with Basal-IQ Technology demonstrated a 31 percent relative reduction in time spent below 70 mg/dL, with no rebound hyperglycemia compared to a CGM-enabled insulin pump without the feature. The system received high usability scores in the study, with 93 percent of participants indicating that the system was easy to use, and 97 percent indicating that they felt confident using the system. [4] This launch marks the achievement of our goal to offer people with diabetes a simple-to-use automated Continue reading >>

Program Expired

Program Expired

Thank you for your interest in the t:slim X2 Upgrade Program. This program ran from October 24, 2016 through September 30, 2017. Though this program is no longer available, we have a team of Pump Therapy Specialists who can work with you to review your insurance benefits to help determine your lowest out-of-pocket option for getting a new Tandem pump. Call us at (877) 801-6901, Monday – Friday from 6am to 5pm Pacific Time, or click the “Get Started” button in the menu above. About the t:slim X2™ Insulin Pump: The simple-to-use t:slim X2™ Insulin Pump is the smallest pump available, the only pump capable of remote feature updates, and the only available pump that is compatible with Dexcom G5® Mobile continuous glucose monitoring (CGM).1-4 Explore the t:slim X2 Pump 38% smaller than MiniMed 630G and 670G and at least 28% smaller than MiniMed 530G, Animas Vibe and Omnipod System. Data on file, Tandem Diabetes Care. Additional feature updates are not currently available for the t:slim X2 Pump with Dexcom G5 CGM integration and are subject to future FDA approvals. Charges may apply. Dexcom G5 Mobile CGM sold separately. CGM coverage may vary based on insurance. Please consult your CGM supplier for coverage information. Continue reading >>

Tidepool

Tidepool

Hi. I know this may read like an advertorial, but this is just me and my personal opinion, and I happen to be sharing it on the Tidepool blog. Christopher Snider A few weeks ago I completed my training through Tandems patient portal on their new Basal-IQ feature and updated my t:slim X2 insulin pump with their shiny new feature. I learned how my insulin pump was going to rely on Dexcom G6 CGM data to make decisions about how much insulin it was going to deliver. I confirmed I understood that my insulin pumps new algorithm would look ahead 30 minutes and automatically stop delivering insulin if it detected my blood glucose levels would drop below 80 mg/dL or if my blood glucose is currently below 70 mg/dL and falling. I must confess the specific act of updating my insulin pump scares me. I successfully updated my pump last time a new feature integrating Dexcom G5 data was available for my t:slim X2. Everything went fine then. And everything went fine this time. But working for a software company has opened my eyes to the challenging reality of thorough testing, quality documentation, and precise validation for any kind of update. Publishing a bug fix for Tidepool Uploader is one thing. Updating the technology that is literally keeping me alive day-to-day is another. Kudos to the team at Tandem for this one. I can only imagine the rigorous testing that was involved in getting this new feature ready for the public. Once everything was up and running and I successfully inserted my first Dexcom G6 sensor (yes, it is as painless as everyone says), I waited the two hours it takes to get my CGM data flowing. Since then, Ive made a few observations about how this entire system Basal-IQ and Dexcom G6 has highlighted some specific aspects of how I manage my diabetes. Observations Continue reading >>

More in insulin